TIAA CREF Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $4.16M | Buy |
510,408
+1,900
| +0.4% | +$15.5K | ﹤0.01% | 1567 |
|
|
2018
Q4 | $4.1M | Buy |
508,508
+3,402
| +0.7% | +$27.5K | ﹤0.01% | 1506 |
|
|
2018
Q3 | $3.85M | Sell |
505,106
-33,189
| -6% | -$253K | ﹤0.01% | 1751 |
|
|
2018
Q2 | $3.08M | Sell |
538,295
-9,851
| -2% | -$56.4K | ﹤0.01% | 1933 |
|
|
2018
Q1 | $2.62M | Sell |
548,146
-1,255
| -0.2% | -$5.99K | ﹤0.01% | 1960 |
|
|
2017
Q4 | $2.7M | Buy |
549,401
+47,471
| +9% | +$233K | ﹤0.01% | 1968 |
|
|
2017
Q3 | $2.63M | Buy |
501,930
+33,048
| +7% | +$173K | ﹤0.01% | 2011 |
|
|
2017
Q2 | $2.61M | Buy |
468,882
+116,782
| +33% | +$649K | ﹤0.01% | 2025 |
|
|
2017
Q1 | $2.96M | Sell |
352,100
-7,922
| -2% | -$66.6K | ﹤0.01% | 1907 |
|
|
2016
Q4 | $2.28M | Sell |
360,022
-25,317
| -7% | -$160K | ﹤0.01% | 2117 |
|
|
2016
Q3 | $1.7K | Sell |
385,339
-2,811
| -0.7% | -$12 | ﹤0.01% | 2260 |
|
|
2016
Q2 | $1.1M | Buy |
388,150
+61,277
| +19% | +$174K | ﹤0.01% | 2457 |
|
|
2016
Q1 | $925K | Hold |
326,873
| – | – | ﹤0.01% | 2515 |
|
|
2015
Q4 | $3.37M | Sell |
326,873
-10,844
| -3% | -$112K | ﹤0.01% | 1825 |
|
|
2015
Q3 | $3.85M | Sell |
337,717
-13,014
| -4% | -$148K | ﹤0.01% | 1718 |
|
|
2015
Q2 | $5.24M | Sell |
350,731
-2,307
| -0.7% | -$34.4K | ﹤0.01% | 1651 |
|
|
2015
Q1 | $3.19M | Buy |
353,038
+484
| +0.1% | +$4.37K | ﹤0.01% | 1931 |
|
|
2014
Q4 | $4.29M | Sell |
352,554
-15,600
| -4% | -$190K | ﹤0.01% | 1731 |
|
|
2014
Q3 | $3.6M | Buy |
368,154
+16,926
| +5% | +$166K | ﹤0.01% | 1840 |
|
|
2014
Q2 | $4.48M | Buy |
+351,228
| New | +$4.48M | ﹤0.01% | 1765 |
|
|
2013
Q3 | – | Sell |
-4,886
| Closed | -$8K | – | 3094 |
|
|
2013
Q2 | $8K | Buy |
+4,886
| New | +$8K | ﹤0.01% | 3094 |
|